...
首页> 外文期刊>Journal of Clinical Microbiology >Genetic Diversity of Borrelia burgdorferi in Lyme Disease Patients as Determined by Culture versus Direct PCR with Clinical Specimens
【24h】

Genetic Diversity of Borrelia burgdorferi in Lyme Disease Patients as Determined by Culture versus Direct PCR with Clinical Specimens

机译:通过文化与直接PCR与临床标本确定莱姆病患者伯氏疏螺旋体的遗传多样性。

获取原文

摘要

Two hundred seventeen isolates of Borrelia burgdorferioriginally cultured from skin biopsy samples or blood of early Lyme disease patients were genetically characterized by PCR-restriction fragment length polymorphism (RFLP) typing of the 16S-23S ribosomal DNA intergenic spacer. Three major RFLP types were observed. Of the cultured isolates, 63 of 217 (29.0%) were type 1, 85 of 217 (39.2%) were type 2, and 58 of 217 (26.7%) were type 3; mixtures of two RFLP types were obtained in 6.0% (13 of 217) of the cultures. Comparison of typing of B. burgdorferi performed directly on 51 patient skin specimens with typing of cultures originally isolated from the same tissue revealed that a much larger proportion of direct tissue samples had mixtures of RFLP types (43.1% by direct typing versus 5.9% by culture [P < 0.001). In addition, identical RFLP types were observed in only 35.5% (11 of 31) of the paired samples. RFLP type 3 organisms were recovered from blood at a significantly lower rate than were either type 1 or type 2 strains. These studies demonstrate that the genetic diversity of B. burgdorferi patient isolates as determined by cultivation differs from that assessed by PCR performed directly on patient tissue.
机译:从16S-23S核糖体DNA基因间隔子的PCR限制性片段长度多态性(RFLP)分型,对最初从莱姆病早期患者的皮肤活检样品或血液中培养的213株疏氏疏螺旋体进行了遗传鉴定。观察到三种主要的RFLP类型。在培养的分离物中,217型中的63株(占29.0%)属于1型,217型中的85株(占39.2%)属于2型,217株中的58株(占26.7%)属于3型。在6.0%(217个中的13个)培养物中获得了两种RFLP类型的混合物。 B类型的比较。 burgdorferi 直接对51例患者皮肤样本进行了标本分离,该标本最初是从同一组织中分离出来的培养物,结果表明,更大比例的直接组织样品具有RFLP类型的混合物(直接标本为43.1%,而培养物为5.9%[ em> P <0.001)。此外,在配对样本中仅35.5%(31个中的11个)中观察到相同的RFLP类型。从血液中回收的RFLP 3型生物比1型或2型菌株的回收率低得多。这些研究表明 B的遗传多样性。通过培养确定的burgdorferi患者分离株与直接在患者组织上进行PCR评估的分离株不同。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号